Ranbaxy will get Approval Fron USFDA next week for molecules

Ranbaxy will get Approval Fron USFDA next week for molecules as last week USA FDA Division visited in Mohali plant and said that your plant is well above my expectations.so buy Ranbaxy as much as u can. Ranbaxy also breaks his 150 DMA on friday So both technically it is very strong so buy Ranbaxy for the target of 650. In month of November they are going to launch a Lipitator in Europe, Ranbaxy and Pfizer has monoply for that product so it is going to give u very high return in this year and will regain no.1 spot in India in pharma sector